These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24335843)

  • 41. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; Domínguez MJ; Covelo M; Fernández JR; Fontao MJ; López JE
    Chronobiol Int; 2004 Mar; 21(2):277-96. PubMed ID: 15332347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensive effect of a novel calcium antagonist, SD-3211, in experimental hypertensive rats.
    Takada T; Miyawaki N; Kageyama M; Matsuno K; Ishida N; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):855-62. PubMed ID: 1725898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.
    Elliott HL; Meredith PA; Sumner DJ; McLean K; Reid JL
    Br J Clin Pharmacol; 1982 May; 13(5):699-703. PubMed ID: 6123342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypotensive effect of Chamaemelum nobile aqueous extract in spontaneously hypertensive rats.
    Zeggwagh NA; Moufid A; Michel JB; Eddouks M
    Clin Exp Hypertens; 2009 Jul; 31(5):440-50. PubMed ID: 19811353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension.
    Os I; Stokke HP
    Blood Press; 1999; 8(3):184-91. PubMed ID: 10595697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antihypertensive activity of ABBOTT-81282, a nonpeptide angiotensin II antagonist, in the renal hypertensive rat.
    Lee JY; Brune ME; Warner RB; Buckner SB; Winn M; De B; Zydowsky TM; Opgenorth TJ; Kerkman DJ; DeBernardis JF
    Pharmacology; 1993 Sep; 47(3):176-87. PubMed ID: 8415868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical pharmacology of doxazosin in patients with essential hypertension.
    Cubeddu LX; Fuenmayor N; Caplan N; Ferry D
    Clin Pharmacol Ther; 1987 Apr; 41(4):439-49. PubMed ID: 2951051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hypertension and metabolic syndrome in population of one company. Monotherapy with amlodipine and doxazosin].
    Cybulski J; Ceremuzyński L
    Pol Merkur Lekarski; 2002 Jul; 13(73):43-7. PubMed ID: 12362505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
    Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical application of wave intensity for the treatment of essential hypertension.
    Fujimoto S; Mizuno R; Saito Y; Nakamura S
    Heart Vessels; 2004 Jan; 19(1):19-22. PubMed ID: 14685750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SD-3211, a novel benzothiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effects without affecting heart rate and atrioventricular conduction in conscious renal hypertensive dogs.
    Kageyama M; Nishimura K; Takada T; Miyawaki N; Yamauchi H
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):102-7. PubMed ID: 1708042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Fogari E; Salvadeo SA; Ferrari I; Gravina A; Fassi R; Fogari R
    Clin Drug Investig; 2006; 26(9):529-39. PubMed ID: 17163286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Lijnen P; Fagard R; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):461-6. PubMed ID: 2465447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT1-receptor antagonist.
    Lee BH; Seo HW; Kwon KJ; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):375-82. PubMed ID: 10069671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.
    Vincent J; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1983 Jun; 15(6):719-25. PubMed ID: 6135439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypotensive and antihypertensive potential of 4-[(1-phenyl-1H-pyrazol-4-yl) methyl]1-piperazine carboxylic acid ethyl ester: a piperazine derivative.
    Fajemiroye JO; Amaral NO; da Silva EF; Galdino PM; de Oliveira TS; Ghedini PC; Zjawiony JK; Costa EA; Pedrino GR; Menegatti R
    Life Sci; 2014 Sep; 112(1-2):90-6. PubMed ID: 25072354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.